| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 63,3 M € | +8.5% | 58,3 M € | +7.5% | 54,2 M € | +2.9% | 52,7 M € | +12.3% | 46,9 M € | -10.5% | 52,4 M € | -4.2% | 54,7 M € | -9.8% | 60,7 M € | +2.9% | 59,0 M € | +6.7% | 55,3 M € | +44.1% | 38,3 M € | +72.7% | 22,2 M € | +5.9% | 21,0 M € | +0.4% | 20,9 M € | -0.8% | 21,1 M € | +204.3% | 6,9 M € | |
| EBITDA | 2,1 M € | +8.9% | 2,0 M € | +32.8% | 1,5 M € | -8.5% | 1,6 M € | +14.8% | 1,4 M € | +3.5% | 1,4 M € | -23.9% | 1,8 M € | -1.6% | 1,8 M € | -23.4% | 2,4 M € | +2.3% | 2,3 M € | +273.8% | 621,2 k € | -39.3% | 1,0 M € | +8.7% | 941,6 k € | +39.9% | 673,2 k € | -50.1% | 1,3 M € | +322.6% | 319,4 k € | |
| Operating profit | 2,1 M € | +9.0% | 2,0 M € | +31.2% | 1,5 M € | -5.6% | 1,6 M € | +12.0% | 1,4 M € | +2.2% | 1,4 M € | -21.5% | 1,8 M € | -3.7% | 1,8 M € | -15.0% | 2,1 M € | -7.5% | 2,3 M € | +273.4% | 621,2 k € | -38.9% | 1,0 M € | +10.7% | 918,7 k € | +35.1% | 680,1 k € | -47.6% | 1,3 M € | +337.5% | 296,4 k € | |
| Profit/loss | 1,6 M € | +13.3% | 1,4 M € | +29.7% | 1,1 M € | -10.1% | 1,2 M € | +14.7% | 1,0 M € | +1.2% | 1,0 M € | -16.6% | 1,2 M € | -6.5% | 1,3 M € | +0.5% | 1,3 M € | -14.9% | 1,5 M € | +298.5% | 382,2 k € | -40.5% | 642,7 k € | +10.3% | 582,6 k € | +39.1% | 418,7 k € | -46.8% | 787,4 k € | +328.5% | 183,7 k € | |
| Equity | 6,5 M € | -6.4% | 7,0 M € | -1.8% | 7,1 M € | +17.5% | 6,0 M € | +2.6% | 5,9 M € | +21.1% | 4,9 M € | +26.3% | 3,9 M € | +46.1% | 2,6 M € | -54.8% | 5,8 M € | +28.5% | 4,5 M € | +50.5% | 3,0 M € | +14.5% | 2,6 M € | +32.3% | 2,0 M € | +41.4% | 1,4 M € | +42.3% | 989,7 k € | +389.2% | 202,3 k € | |
| Total assets | 17,0 M € | -2.1% | 17,4 M € | +2.3% | 17,0 M € | -20.6% | 21,4 M € | +58.7% | 13,5 M € | +16.2% | 11,6 M € | -5.4% | 12,3 M € | -29.2% | 17,3 M € | +12.3% | 15,4 M € | +6.0% | 14,6 M € | -17.5% | 17,7 M € | +106.2% | 8,6 M € | +38.9% | 6,2 M € | -50.6% | 12,5 M € | +61.0% | 7,7 M € | -21.2% | 9,8 M € | |
| Cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 363,9 k € | -66.8% | 1,1 M € | |||||||||||||||
| Debts | 9,9 M € | -0.1% | 9,9 M € | +5.0% | 9,4 M € | -38.8% | 15,4 M € | +119.7% | 7,0 M € | +6.0% | 6,6 M € | -18.4% | 8,1 M € | -44.4% | 14,5 M € | +55.1% | 9,4 M € | -4.2% | 9,8 M € | -32.8% | 14,5 M € | +144.9% | 5,9 M € | +42.1% | 4,2 M € | -62.3% | 11,1 M € | +81.7% | 6,1 M € | -36.7% | 9,6 M € | |
| Staff | 21,8 | 22 | 20,8 | 18,1 | 15,9 | 15,2 | 13,3 | 13,6 | 12,1 | 11,2 | 9,6 | 8 | 7,8 | 6,7 | 6,3 | 4,8 | ||||||||||||||||
Private limited company · Wavre · incorporated on 20/08/2009 · 21,8 ETP
Private limited company profitable and well capitalised. Cash position declining (-66.8%).
Solid counterparty for a standard engagement.
ViiV Healthcare is a Private limited company incorporated in 2009. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Wavre. It employs on average 21,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette